KYMR - Kymera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

KYMR is currently covered by 23 analysts with an average price target of $134.86. This is a potential upside of $19.55 (16.95%) from yesterday's end of day stock price of $115.31.

Kymera Therapeutics's activity chart (see below) currently has 219 price targets and 214 ratings on display. The stock rating distribution of KYMR is 96.36% BUY and 3.64% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 93.79% of the time, taking 295.32 days on average.

Highest price target for KYMR is $170, Lowest price target is $97, average price target is $134.86.

Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 02-Nov-2026. First documented stock forecast 15-Sep-2020.

Currently out of the existing stock ratings of KYMR, 53 are a BUY (96.36%), 2 are a HOLD (3.64%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-May-2021

$170

$54.69 (47.43%)

$139

19 days ago
(02-Nov-2026)

6/8 (75%)

$42.49 (33.32%)

459

Hold Since 30-Oct-2026

$116

$0.69 (0.60%)

$115

22 days ago
(30-Oct-2026)

5/5 (100%)

$-10.63 (-8.39%)

84

Buy Since 30-Jun-2023

$150

$34.69 (30.08%)

$136

22 days ago
(30-Oct-2026)

13/14 (92.86%)

$23.37 (18.46%)

192

Buy Since 27-Oct-2026

$146

$30.69 (26.62%)

$79

25 days ago
(27-Oct-2026)

2/3 (66.67%)

$28.43 (24.18%)

97

Buy Since 27-Jun-2025

$150

$34.69 (30.08%)

$120

1 months 16 days ago
(05-Oct-2026)

9/10 (90%)

$40.15 (36.55%)

125

Show more analysts

Please expand the browser size to see the chart

What is KYMR (Kymera Therapeutics) average time for price targets to be met?

On average it took 295 days for the stock forecasts to be reached, with an average price target met ratio of 93.79%.

Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?

Eliana Merle

Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?

Eliana Merle works at BARCLAYS and has 3 price targets and 4 ratings on KYMR

Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?

Bradley Canino with the highest potential upside of $54.69

Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?

Richard Law with the lowest potential downside of -$78.31
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?